Ridgefield, CT, United States of America

Justin M Scheer

This inventor holds 32 USPTO granted patents and 8 published patent applications and 1 EPO patent, primarily in Cancer Treatment. Top assignees: Genentech, Inc., Boehringer Ingelheim International Gmbh, New Biology, Inc.. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Justin M Scheer. Retrieved from https://idiyas.com/inventor/justin-m-scheer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 32 (Patent Applications = 8)

% Patents Active = 84.4

EPO Patents = 1 (Patent Applications = 8)

Average Co-Inventor Count = 4.6

ph-index = 5

Forward Citations = 109(Granted Patents)

Location History:

Burlingame, CA (US) (2019)
San Francisco, CA (US) (2011 - 2021)
South San Francisco, CA (US) (2019 - 2021)
Half Moon Bay, CA (US) (2018 - 2023)
Ridgefield, CT (US) (2017 - 2024)

Company Filing History:

Boehringer Ingelheim International Gmbh

Years Active: 2011-2026

Loading Chart...

Areas of Expertise:

Bispecific Antibodies

Cancer Treatment

IL-22 Fusion Proteins

Multi-Specific Binding Proteins

Pharmaceutical Compositions

Anti-Factor D Antibodies

Wound Healing

Metabolic Syndrome

Inflammatory Bowel Disease

Cardiovascular Conditions

Nucleic Acids

Heteromultimeric Proteins

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12774334 - B7H6 X CD3 BINDING PROTEINS FOR CANCER TREATMENT (2026-10-27),

2. 12528879 - MULTI-SPECIFIC BINDING PROTEINS FOR CANCER TREATMENT (2026-01-20),

3. 12173083 - Multi-specific binding proteins for cancer treatment (2024-12-24),

4. 12146000 - Bispecific and tetravalent CD137 and FAP molecules for the treatment of cancer (2024-11-19),

5. 12110335 - Bispecific anti-VEGF and anti-TrkB binding molecules for the treatment of eye diseases (2024-10-08),

6. 11732045 - Multi-specific binding proteins for cancer treatment (2023-08-22),

7. 11725065 - Assembly of bispecific antibodies (2023-08-15),

8. 11332541 - Multi-specific binding proteins for cancer treatment (2022-05-17),

9. 11332507 - IL-22 Fc fusion proteins (2022-05-17),

10. 11192950 - Humanized and affinity matured antibodies to FcRH5 and methods of use (2021-12-07),

11. 11155591 - Methods of treating acute pancreatitis using IL-22 fc fusion proteins (2021-10-26),

12. 11136365 - Methods for preventing or treating cardiovascular conditions using il-22 fc fusion proteins (2021-10-05),

13. 11130791 - Methods for treating metabolic syndrome using IL-22 Fc fusion proteins (2021-09-28),

14. 10961313 - Anti-factor D antibody variant conjugates and uses thereof (2021-03-30),

15. 10941190 - Production of heteromultimeric proteins using mammalian cells (2021-03-09),

Title: Justin M Scheer - Innovative Inventor from Ridgefield

Introduction: Justin M Scheer is a talented inventor based in Ridgefield, CT, known for his groundbreaking contributions to various industries.

Latest Patents: Justin M Scheer holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Justin M Scheer has consistently demonstrated a passion for innovation and a keen eye for identifying market needs.

Collaborations: Throughout his career, Justin M Scheer has collaborated with leading companies, research institutions, and universities to bring his inventions to life and make a positive impact on society.

Conclusion: Justin M Scheer's dedication to pushing the boundaries of what is possible through his inventions makes him a true pioneer in the world of innovation.

Profile summary based on public USPTO records.